BILLS-117hr3537enr.pdf

the fourth day of January later than 4 years Monday title 21 2026 one year later than 6 months 42 U.S.C. 5-year 1965 later than one year 1986 each of fiscal years 2022 42 U.S.C. 284a September 30, 2026 days

the ‘‘Accelerating Access to Critical Therapies

the United States Washington the United States of America the City of United States of America

SEC Senate the Food and Drug Administration Health and Human Services ALS the Commissioner of Food and Drugs the Federal Food, Drug the Food and Drug Administration FUNDS.—A the House of Representatives the Small Business Act the Federal Food U.S.C. House the Comptroller General the Federal Food, Drug House of Representatives the Public Health Service Drug Administration HHS Congress non-Federal the Food and Drug Administration the Committee on Energy and Commerce of Partnership Drug Department of Health and Human Services Federal Food, Drug the Committee on Health, Education Drug Administration GAO Health and Human Services APPROPRIATIONS the Internal Revenue Code Labor the National Institutes of Health

H. R. 3537—6 H. R. 3537—2 H. R. 3537 H. R. 3537—3 H. R. 3537—5 H. R. 3537—4

lateral sclerosis amyotrophic lateral amyotrophic sclerosis cure amyotrophic lateral investigational expanded access clinical trial cure clinical rare clinical trials drug administration food drug